SHG · Industrials

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153)

Engineering & Construction

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) is listed on SHG in the Industrials sector. Industry: Engineering & Construction. As of 2026-03-28, reported market cap is $6.44B, P/E ratio is 17.27, net margin is 8.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 603153

Market cap
$6.44B
P/E ratio
17.27
Gross profit (TTM)
$1.51B
Net margin
8.9%

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) — FAQ

What is Shanghai Research Institute of Building Sciences Group Co. Ltd A's market cap?

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) has a reported market cap of $6.44B (data as of 2026-03-28).

What is 603153's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) is 17.27 (data as of 2026-03-28).

Does Shanghai Research Institute of Building Sciences Group Co. Ltd A pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Research Institute of Building Sciences Group Co. Ltd A in?

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) is classified in the Industrials sector (Engineering & Construction industry).

What exchange is 603153 listed on?

603153 is listed on SHG.

What is Shanghai Research Institute of Building Sciences Group Co. Ltd A's net margin?

Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153) reports a net margin of 8.9% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Industrials companies

App Store Google Play